| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.061 | 0.2 |